Bio-Techne (TECH) Gross Margin Growth (3y) (2012 - 2026)

Bio-Techne (TECH) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn -184.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -184.00
Dec 31, 2025 -287.00
Sep 30, 2025 -891,410.00
Jun 30, 2025 -679.00
Mar 31, 2025 -152.00
Dec 31, 2024 -294.00
Sep 30, 2024 -312.00
Jun 30, 2024 -149.00
Mar 31, 2024 -166.00
Dec 31, 2023 -251.00
Sep 30, 2023 -58.00
Jun 30, 2023 349.00
Mar 31, 2023 192.00
Dec 31, 2022 187.00
Sep 30, 2022 891,513.00
Jun 30, 2022 259.00
Mar 31, 2022 197.00
Dec 31, 2021 345.00
Sep 30, 2021 32.00
Jun 30, 2021 14.00